NeuRA Imaging Centre

FACILITY INFORMATION

MRI scanner
Philips 3 Tesla Achieva TX scanner. 32 receiver channel RX system, Multitransmit TX.  Max gradient strength 80 mT/m, max slew rate 200mT/m/ms. Second, broadband transmit channel (13C and 31P). Range of coils for most body parts. 32 channel extremities coil, 32 channel head coil, 4 channel RF rat/mouse coil.

MRI components and services
– LCD screen for presentation of fMRI paradigms
– Trigger (press button) box for recording responses
– Computer (PSYCHO) for presenting fMRI paradigms and for recording psychophysics data. PSYCHO operates a range of common presentation software (yours can be loaded on request).
– PSYCHO II (back up system which is replica of PSYCHO).
– 3T compatible patient physiological monitoring system (Schiller) for heart rate, respiration, blood pressure, expired gasses (CO2, O2), pulse oximeter.
– MRI compatible EEG system (BrainProducts)
– VCG gating.
– Permanent archiving of all raw (DICOM) data.
– Full radiography service.
– Full Philips maintenance service.
– Radiologist duty of care report on all relevant scans.

SR Research Eye Tracker
EyeLink 1000 system with the following characteristics:
– Non-ferromagnetic optimized design with up to 2000 Hz sampling rate
– Down to 0.01º RMS spatial resolution amd real-time eye position access of 1.4 msec (SD < 0.4 msec) @ 2000 Hz
– Supports Camera-to-eye distances of 60 – 150 cm

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

The cold case of schizophrenia - broken wide open!

‘It is like they were miraculously healed!’’ Schizophrenia is diagnosed by clinical observation of behaviour and speech. This is why NeuRA researchers are working hard to understand the biological basis of the illness. Through hours of work and in collaboration with doctors and scientists here and around the world, NeuRA has made an amazing breakthrough. For the first time, researchers have discovered the presence of antibodies in the brains of people who lived with schizophrenia. Having found these antibodies, it has led NeuRA researchers to ask two questions. What are they doing there? What should we do about the antibodies– help or remove them? This is a key breakthrough. Imagine if we are treating schizophrenia all wrong! It is early days, but can you imagine the treatment implications if we’ve identified a new biological basis for the disease? It could completely change the way schizophrenia is managed, creating new treatments that will protect the brain. More than this, could we be on the verge of discovering a ‘curable’ form of schizophrenia? How you can help We are so grateful for your loyal support of schizophrenia research in Australia, and today I ask if you will consider a gift today. Or, to provide greater confidence, consider becoming a Discovery Partner by making a monthly commitment. We believe there is great potential to explore these findings. Will you help move today’s breakthrough into tomorrow’s cure? To read more about this breakthrough, click ‘read the full story’ below. You are also invited to read ‘Beth’s story’, whose sweet son Marcus lived with schizophrenia, by clicking here.
APPEAL